EE05402B1 - Meetod bensimidasooli-tüüpi ühendite valmistamiseks ning k?rvalsaadusena moodustunud sulfoonide eemaldamiseks - Google Patents
Meetod bensimidasooli-tüüpi ühendite valmistamiseks ning k?rvalsaadusena moodustunud sulfoonide eemaldamiseksInfo
- Publication number
- EE05402B1 EE05402B1 EEP200400052A EEP200400052A EE05402B1 EE 05402 B1 EE05402 B1 EE 05402B1 EE P200400052 A EEP200400052 A EE P200400052A EE P200400052 A EEP200400052 A EE P200400052A EE 05402 B1 EE05402 B1 EE 05402B1
- Authority
- EE
- Estonia
- Prior art keywords
- benzimidazole
- preparation
- sulfones
- removal
- products
- Prior art date
Links
- 239000006227 byproduct Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000003457 sulfones Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 abstract 1
- IQPSEEYGBUAQFF-UHFFFAOYSA-N Pantoprazole Chemical compound COC1=CC=NC(CS(=O)C=2NC3=CC=C(OC(F)F)C=C3N=2)=C1OC IQPSEEYGBUAQFF-UHFFFAOYSA-N 0.000 abstract 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 abstract 1
- 239000012670 alkaline solution Substances 0.000 abstract 1
- 229960004770 esomeprazole Drugs 0.000 abstract 1
- SUBDBMMJDZJVOS-DEOSSOPVSA-N esomeprazole Chemical compound C([S@](=O)C1=NC2=CC=C(C=C2N1)OC)C1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-DEOSSOPVSA-N 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 229960003174 lansoprazole Drugs 0.000 abstract 1
- MJIHNNLFOKEZEW-UHFFFAOYSA-N lansoprazole Chemical compound CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1 MJIHNNLFOKEZEW-UHFFFAOYSA-N 0.000 abstract 1
- 229960000381 omeprazole Drugs 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 229960005019 pantoprazole Drugs 0.000 abstract 1
- 229940126409 proton pump inhibitor Drugs 0.000 abstract 1
- 239000000612 proton pump inhibitor Substances 0.000 abstract 1
- 229960004157 rabeprazole Drugs 0.000 abstract 1
- YREYEVIYCVEVJK-UHFFFAOYSA-N rabeprazole Chemical compound COCCCOC1=CC=NC(CS(=O)C=2NC3=CC=CC=C3N=2)=C1C YREYEVIYCVEVJK-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preventing Corrosion Or Incrustation Of Metals (AREA)
- Extraction Or Liquid Replacement (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01202696 | 2001-07-16 | ||
| PCT/EP2002/007693 WO2003008406A1 (en) | 2001-07-16 | 2002-07-09 | Improved process for preparing benzimidazole-type compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200400052A EE200400052A (et) | 2004-04-15 |
| EE05402B1 true EE05402B1 (et) | 2011-04-15 |
Family
ID=8180641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200400052A EE05402B1 (et) | 2001-07-16 | 2002-07-09 | Meetod bensimidasooli-tüüpi ühendite valmistamiseks ning k?rvalsaadusena moodustunud sulfoonide eemaldamiseks |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6919459B2 (cs) |
| EP (1) | EP1409478B1 (cs) |
| JP (1) | JP4320250B2 (cs) |
| KR (1) | KR100914175B1 (cs) |
| CN (1) | CN1235899C (cs) |
| AT (1) | ATE321758T1 (cs) |
| AU (1) | AU2002321204B2 (cs) |
| BR (1) | BRPI0211101B8 (cs) |
| CA (1) | CA2450433C (cs) |
| CZ (1) | CZ304526B6 (cs) |
| DE (1) | DE60210292T2 (cs) |
| EA (1) | EA005773B1 (cs) |
| EE (1) | EE05402B1 (cs) |
| ES (1) | ES2261703T3 (cs) |
| HU (1) | HU230155B1 (cs) |
| IL (2) | IL159854A0 (cs) |
| MX (1) | MXPA04000433A (cs) |
| NO (1) | NO324257B1 (cs) |
| NZ (1) | NZ530168A (cs) |
| PL (1) | PL208291B1 (cs) |
| SK (1) | SK287245B6 (cs) |
| WO (1) | WO2003008406A1 (cs) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0315574A (pt) * | 2002-10-22 | 2005-09-20 | Ranbaxy Lab Ltd | Forma amorfa de esomeprazol, composição farmacêutica contendo o mesmo e processo para sua preparação |
| CA2528993A1 (en) * | 2003-06-10 | 2004-12-23 | Teva Pharmaceutical Industries Ltd. | Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole |
| JP4987477B2 (ja) * | 2004-08-20 | 2012-07-25 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ベンズイミダゾール誘導体の製造方法 |
| WO2006049486A1 (en) * | 2004-11-08 | 2006-05-11 | Dishman Pharmaceuticals And Chemicals Ltd. | A PREPARATION METHOD FOR SUBSTITUTED 2-(2-PYRIDYLMETHOYLSULPHINYL)-l-H-BENZIMID AZOLES |
| EP1681056A1 (en) | 2005-01-14 | 2006-07-19 | Krka Tovarna Zdravil, D.D., Novo Mesto | Process for preparing lansoprazole |
| GB0525710D0 (en) * | 2005-12-17 | 2006-01-25 | Pliva Hrvatska D O O | An improved process for preparing of substituted 2-benzimidazolesulfoxide compounds |
| EP1801110A1 (en) | 2005-12-22 | 2007-06-27 | KRKA, tovarna zdravil, d.d., Novo mesto | Esomeprazole arginine salt |
| EP1818331A1 (en) | 2006-02-14 | 2007-08-15 | EOS Eczacibasi Ozgun Kimyasal Urunler Sanayi Ve Ti Caret A.S. | Process for the preparation of 2-[{4-(3-methoxypropoxy)-3-methylpyridin-2-yl}methylsulfinyl]-1H-benzimidazole substantially free of sulfone impurity |
| WO2007129328A2 (en) * | 2006-05-09 | 2007-11-15 | Cadila Healthcare Limited | Process for preparing 2-[pyridinyl]sulfinyl-substituted benzimidazoles |
| WO2007138468A2 (en) * | 2006-06-01 | 2007-12-06 | Wockhardt Ltd | Processes for the preparation of lansoprazole |
| WO2008017020A2 (en) * | 2006-08-03 | 2008-02-07 | Dr. Reddy's Laboratories Limited | Process for preparing proton pump inhibitors |
| EP2069329A4 (en) * | 2006-10-06 | 2010-04-07 | Reddys Lab Ltd Dr | PROCESS FOR THE PREPARATION OF BENZIMIDAZOLE DERIVATIVES AND THEIR SALTS |
| EP1947099A1 (en) | 2007-01-18 | 2008-07-23 | LEK Pharmaceuticals D.D. | Process for solvent removal from omeprazole salts |
| EA016297B1 (ru) * | 2007-06-15 | 2012-03-30 | Эмкьюр Фармасьютикалз Лимитед | Способ сульфоксидирования биологически активных соединений |
| US8247568B2 (en) * | 2007-06-21 | 2012-08-21 | Matrix Laboratories Ltd | Process for the preparation of pure rabeprazole |
| EP2022789A1 (en) * | 2007-08-06 | 2009-02-11 | Farmaprojects, S.A. | Process for the preparation of a gastric acid secretion inhibitor |
| WO2009066317A2 (en) * | 2007-08-20 | 2009-05-28 | Macleods Pharmaceuticals Limited | Process for the preparation of pantoprazole sodium |
| EP2030973A1 (en) * | 2007-08-31 | 2009-03-04 | KRKA, tovarna zdravil, d.d., Novo mesto | Process for preparing 2-sulfinyl-1H-benzimidazoles |
| US8071781B2 (en) | 2008-11-11 | 2011-12-06 | Syn-Tech Chem. & Pharm. Co., Ltd. | Process for preparing rabeprazole sodium |
| JP5797210B2 (ja) * | 2010-03-02 | 2015-10-21 | シアトル ジェネティックス, インコーポレイテッド | 抗体をスクリーニングするための方法 |
| CN104418837A (zh) * | 2013-08-19 | 2015-03-18 | 长沙市如虹医药科技有限公司 | 一种氧化硫醚成亚砜的方法 |
| CN104402867A (zh) * | 2014-11-07 | 2015-03-11 | 烟台万润精细化工股份有限公司 | 一种制备埃索美拉唑杂质h和b的方法 |
| CN104402866A (zh) * | 2014-11-07 | 2015-03-11 | 烟台万润精细化工股份有限公司 | 一种制备埃索美拉唑杂质j和k的方法 |
| CN104530006B (zh) * | 2015-01-06 | 2018-05-11 | 江苏奥赛康药业股份有限公司 | 兰索拉唑的制备方法 |
| CN104744440B (zh) * | 2015-03-12 | 2016-09-07 | 常州康丽制药有限公司 | 雷贝拉唑硫醚的回收方法 |
| CN110487918B (zh) * | 2018-05-14 | 2022-02-08 | 中国医学科学院药物研究所 | 泮托拉唑钠及其起始原料中基因毒性杂质的分析方法 |
| CN109354587B (zh) * | 2018-10-18 | 2020-09-18 | 成都天台山制药有限公司 | 泮托拉唑钠的制备方法和泮托拉唑钠 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9002043D0 (sv) * | 1990-06-07 | 1990-06-07 | Astra Ab | Improved method for synthesis |
| WO1993006097A1 (en) * | 1991-09-20 | 1993-04-01 | Merck & Co., Inc. | Novel process for the preparation of anti-ulcer agents |
| KR960002912B1 (ko) * | 1993-02-19 | 1996-02-28 | 영진약품공업주식회사 | 신규한 벤즈이미다졸 유도체 |
| ES2094694B1 (es) | 1995-02-01 | 1997-12-16 | Esteve Quimica Sa | Nueva formulacion farmaceuticamente estable de un compuesto de bencimidazol y su proceso de obtencion. |
| CN1053444C (zh) * | 1996-03-20 | 2000-06-14 | 常州市第四制药厂 | 奥美拉唑的一种精制方法 |
| SK283805B6 (sk) * | 1996-09-09 | 2004-02-03 | Slovakofarma, A. S. | Spôsob prípravy omeprazolu |
| SI20019A (sl) * | 1998-07-13 | 2000-02-29 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola |
-
2002
- 2002-07-09 EA EA200400185A patent/EA005773B1/ru not_active IP Right Cessation
- 2002-07-09 DE DE60210292T patent/DE60210292T2/de not_active Expired - Lifetime
- 2002-07-09 US US10/483,587 patent/US6919459B2/en not_active Expired - Lifetime
- 2002-07-09 EP EP02754865A patent/EP1409478B1/en not_active Expired - Lifetime
- 2002-07-09 IL IL15985402A patent/IL159854A0/xx unknown
- 2002-07-09 CZ CZ2004-208A patent/CZ304526B6/cs not_active IP Right Cessation
- 2002-07-09 AU AU2002321204A patent/AU2002321204B2/en not_active Expired
- 2002-07-09 CN CNB028139615A patent/CN1235899C/zh not_active Expired - Lifetime
- 2002-07-09 BR BRPI0211101A patent/BRPI0211101B8/pt not_active IP Right Cessation
- 2002-07-09 AT AT02754865T patent/ATE321758T1/de not_active IP Right Cessation
- 2002-07-09 KR KR1020037015941A patent/KR100914175B1/ko not_active Expired - Lifetime
- 2002-07-09 PL PL367006A patent/PL208291B1/pl unknown
- 2002-07-09 HU HU0400610A patent/HU230155B1/hu unknown
- 2002-07-09 NZ NZ530168A patent/NZ530168A/en not_active IP Right Cessation
- 2002-07-09 SK SK92-2004A patent/SK287245B6/sk not_active IP Right Cessation
- 2002-07-09 JP JP2003513965A patent/JP4320250B2/ja not_active Expired - Lifetime
- 2002-07-09 ES ES02754865T patent/ES2261703T3/es not_active Expired - Lifetime
- 2002-07-09 WO PCT/EP2002/007693 patent/WO2003008406A1/en not_active Ceased
- 2002-07-09 CA CA2450433A patent/CA2450433C/en not_active Expired - Lifetime
- 2002-07-09 MX MXPA04000433A patent/MXPA04000433A/es active IP Right Grant
- 2002-07-09 EE EEP200400052A patent/EE05402B1/xx unknown
-
2004
- 2004-01-08 NO NO20040074A patent/NO324257B1/no not_active IP Right Cessation
- 2004-01-14 IL IL159854A patent/IL159854A/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE05402B1 (et) | Meetod bensimidasooli-tüüpi ühendite valmistamiseks ning k?rvalsaadusena moodustunud sulfoonide eemaldamiseks | |
| TR200201072T2 (tr) | 4-Triflorometilsulfinilpirazol türevi hazırlama süreci | |
| BG97146A (bg) | Усъвършенствуван метод за синтез | |
| NO20016087D0 (no) | Benzimidazolforbindelsekrystall | |
| DE60111362D1 (de) | Stabilisierte ascorbinsäure-lösungen | |
| FI20010705L (fi) | Menetelmä peretikkahapon valmistamiseksi | |
| NO20052474L (no) | Amort form av esomeprazolsalter | |
| SE0104295D0 (sv) | New process | |
| MXPA03006904A (es) | Procesos para la produccion de 2-(2-piridilmetil) sulfinil - 1h - bencimidazoles sustituidos. | |
| ATE338027T1 (de) | Herstellung von iminodiessigsäure-derivaten aus monoethanolamin-substraten | |
| MXPA02010039A (es) | Procedimiento para la obtencion de derivados de 1[[piridil sustituido)metil]tio]bencimidazol. | |
| NO20040604L (no) | Trisykliske imidazolpyridiner | |
| DE60211758D1 (de) | Verfahren zur herstellung von sulfinylderivaten mittels oxidation der entsprechenden sulfide | |
| DK1140788T3 (da) | Fremgangsmåde til fremstilling af arylethere | |
| WO2001068594A1 (es) | Procedimiento de oxidacion de un grupo tioeter a sulfoxido | |
| ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren | |
| DK1335913T3 (da) | Fremgangsmåde til fremstilling af pantoprazol og intermediære deraf | |
| JP2019194219A (ja) | 光学活性のプロトンポンプ阻害化合物の製造方法 | |
| SE0302382D0 (sv) | New salts II | |
| RU2003137221A (ru) | Комплекс включения s-омепразола (эсомепразола) с циклодекстрином | |
| EA200501125A1 (ru) | Способ получения метил-2-дифенилметилсульфинилацетата | |
| SE0400410D0 (sv) | New compounds | |
| CY1105987T1 (el) | Παραγωγα πυριδινο-2-υλο-μεθυλαμινης για την θepαπεια της εξαρτησης απο τα οπιοειδη | |
| WO2008087665A3 (en) | Process for preparation of lansoprazole | |
| UY26420A1 (es) | Procedimiento mejorado para la preparación de derivados bencimidazol adecuados como fármacos antiulcerosos, particularmente omeprazol o pantoprazol |